Show
Sort by
-
Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab plus bortezomib/thalidomide/dexamethasone in the phase III CASSIOPEIA study
-
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA) : an open-label, randomised, phase 3 trial
-
- Journal Article
- A1
- open access
Clinical significance of upper airway virus detection in critically ill hematology patients
-
Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium: a Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique study